GlassScriptPhysician profile
Jason Wen
NPI 1760910244
$37,359.78
in general payments reported to CMS, 2019-2025
27 companies · $9,964 in 2025
The $9,964 reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $118 · 2021: $470 · 2022: $2,357 · 2023: $2,456 · 2024: $22K · 2025: $9,964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $21K · Food and Beverage: $10K · Travel and Lodging: $2,812 · Education: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $20,920.54 |
| Food and Beverage | $10,333.71 |
| Travel and Lodging | $2,811.64 |
| Education | $214.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $18,252.11 | 2022-2025 | Optis, Pressurewire, Coroflow |
| Medtronic, INC. | $6,517.89 | 2021-2025 | Onyx Frontier, Mycarelink |
| Penumbra, INC. | $2,658.47 | 2025 | Indigo System |
| Shockwave Medical, INC | $2,199.49 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $2,090.34 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $1,646.98 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Boston Scientific Corporation | $1,558.14 | 2022-2024 | Sentinel |
| Heartflow, INC. | $576.47 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $365.64 | 2020-2024 | Lifevest |
| Recor Medical INC | $231.28 | 2025 | Paradise Ultrasound Renal Denervation System |
| Philips North America LLC | $210.09 | 2024-2025 | Coronary Other, (Bq9) Coronary Ivus |
| Abbvie INC. | $160.90 | 2023 | Ozurdex |
| Novartis Pharmaceuticals Corporation | $139.39 | 2021-2025 | |
| Amgen INC. | $126.24 | 2021-2024 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $123.06 | 2023 | Arcalyst |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $118.15 | 2021-2023 | |
| Medtronic Vascular, INC. | $91.62 | 2020 | |
| Impulse Dynamics (USA) INC. | $55.00 | 2023 | Optimizer |
| W. L. Gore & Associates, INC. | $50.00 | 2024 | Gore-Tex Vascular Graft |
| Janssen Pharmaceuticals, INC | $35.12 | 2020-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $32.24 | 2022-2023 | Camzyos |
| Asahi Intecc USA, INC. | $29.86 | 2021-2022 | |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Inari Medical, INC. | $21.23 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.27 | 2023 | Farxiga |
| Cardiva Medical, INC. | $13.65 | 2021 | |
| Terumo Medical Corporation | $13.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.